« Previous article
Make Your Mycotoxin ...

18th May 2020  Content supplied by: ProGnosis Biotech S.A

Antibody Tests Against SARS-CoV-2- IgA, IgM, IgG - ELISA & Rapid Tests


ProGnosis Biotech has developed three ELISA kits for the determination of antibodies against SARS-CoV-2 in human serum or plasma specimens. They are Semi-quantitative tests with a single-break strip plate of 48 wells or 96 wells. These tests provide accurate results in under two hours, and they are compatible with ELISA automated systems.

  • Bio-Shield 2019-nCoV IgM: An antibody-capture ELISA kit that determines the IgM antibodies against SARS-CoV-2

Specificity :100% Sensitivity: 96.67%
Duration: 90 min
Shelf life: 12 months

  • Bio-Shield 2019-nCoV IgG: An indirect ELISA kit that determines the IgG antibodies against SARS-CoV-2

Specificity :100% Sensitivity: 97.14%
Duration: 90 min
Shelf life: 12 months

  • Bio-Shield 2019-nCoV Total Immunoglobulins: A double antigen sandwich ELISA kit that determines the IgA, IgM, IgG antibodies against SARS-CoV-2

Specificity :100% Sensitivity: 98.68%
Duration: 120 min
Shelf life: 12 months

ProGnosis Biotech recently launched two rapid tests (lateral flow method), which provide rapid & reliable indication to medical teams about patients’ exposure to SARS-CoV-2. Because of their easy-to-use technique (they do not require any special facilities or equipment) and their short duration, the rapid tests can also be used in points of entry such as ports and airports.

  • Rapid test 2019-nCoV Total Ig: detects the antibodies (IgA, IgM, IgG) against SARS-CoV-2

Duration: 10 min
Shelf life: 12 months

  • Rapid test 2019-nCoV IgM/IgG: detects the IgM & IgG antibodies against SARS-CoV-2

Duration: 10 min
Shelf life: 12 months


    

Tags:

Date Published: 18th May 2020

Source article link: View


View full company details